Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABCC8 (SUR1) is the regulatory subunit of the ATP-sensitive potassium (KATP) channel, primarily found in pancreatic beta cells. It plays a crucial role in glucose-stimulated insulin secretion by controlling membrane potential in response to intracellular ATP/ADP levels. Mutations in ABCC8 are associated with congenital hyperinsulinism and permanent neonatal diabetes mellitus. It is also a target for sulfonylurea drugs used in the treatment of type 2 diabetes.
Sulfonylureas bind to SUR1, causing closure of KATP channels, which leads to membrane depolarization and increased insulin secretion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-binding cassette transporter sub-family C member 8 (ABCC8/SUR1).